Hence, while the relationship between IL-1β and PD-1/PD-L1 pathways in the TME of NSCLC is significant, further research is needed to elucidate the exact mechanisms and improve outcomes with IL-1β and PD-1/PD-L1 inhibitors. Here, CD274 is linked to non-small cell lung carcinoma.